This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Universidad De Concepción, Ichor Biologics, LLC, Ichor Biologies, LLC. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Innovations by Felipe Edgardo Bravo Caceres
Introduction
Felipe Edgardo Bravo Caceres is a notable inventor based in Concepcion, Chile. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of two patents to his name, his work has the potential to impact public health positively.
Latest Patents
Bravo Caceres' latest patents include "Antibodies to Andes hantavirus, and methods for using same." This invention provides isolated human antibodies and recombinant proteins comprising defined heavy chains and light chains. The antibodies and recombinant proteins are designed to neutralize the Andes Virus with defined IC50 values. Additionally, this invention offers related pharmaceutical compositions, treatment methods, and kits, showcasing his innovative approach to combating viral infections.
Career Highlights
Throughout his career, Bravo Caceres has worked with esteemed organizations such as Universidad De Concepcion and Ichor Biologics, LLC. His experience in these institutions has allowed him to collaborate with other professionals in the field and further his research endeavors.
Collaborations
Some of his notable coworkers include Maria Ines Barria and Jose Luis Garrido Ramirez. Their collaborative efforts have contributed to the advancement of research in biotechnology and the development of effective treatments.
Conclusion
Felipe Edgardo Bravo Caceres is a distinguished inventor whose work in developing antibodies against the Andes hantavirus demonstrates his commitment to innovation in biotechnology. His contributions have the potential to lead to significant advancements in medical treatments and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile